PTC Therapeutics, Inc. (PTCT) Operating cash flow 2016–2025
PTC Therapeutics, Inc. (PTCT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$711.2MFY2025 · since FY2016: -$103.6M → $711.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $711.2M | +760.4% |
| FY2024 | -$107.7M | +32.0% |
| FY2023 | -$158.4M | +55.6% |
| FY2022 | -$356.7M | -41.9% |
| FY2021 | -$251.3M | -29.5% |
| FY2020 | -$194.1M | -96.7% |
| FY2019 | -$98.6M | -256.9% |
| FY2018 | -$27.6M | -174.7% |
| FY2017 | -$10.1M | +90.3% |
| FY2016 | -$103.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PTCT financial trends
PTCT RevenuePTCT Net incomePTCT Net marginPTCT Gross profitPTCT Gross marginPTCT Operating incomePTCT Operating marginPTCT Free cash flowPTCT Capital expendituresPTCT Return on equityPTCT Stock buybacksPTCT Dividends paidPTCT Total assetsPTCT Total liabilitiesPTCT Shareholders’ equityPTCT overview →